Page last updated: 2024-08-22

angiotensin ii and Diabetes Mellitus

angiotensin ii has been researched along with Diabetes Mellitus in 132 studies

Research

Studies (132)

TimeframeStudies, this research(%)All Research%
pre-199037 (28.03)18.7374
1990's10 (7.58)18.2507
2000's48 (36.36)29.6817
2010's24 (18.18)24.3611
2020's13 (9.85)2.80

Authors

AuthorsStudies
Mosquera, J; Munoz, N; Pedreanez, A; Robalino, J; Tene, D1
Baglieri, C; Capelli, C; Casolo, A; Conti, E; Gattoni, C; Girardi, M; Jurkiewicz, A; Jurkiewicz, NH; Musial, DC; Nuccio, S; Rocha, K; Souza Bomfim, GH1
Han, P; Jensen, DM; Kriegel, AJ; Liang, M; Liu, J; Lopez-Berestein, G; Mangala, LS; Sood, AK; Usa, K; Widlansky, ME1
Capozzi, ME; Padovani-Claudio, DA; Penn, JS; Ramos, CJ1
Ferder, L; García Menéndez, S; Inserra, F; Manucha, W; Mazzei, L; Sanz, RL1
Abraham, NG; Arad, M; Aravot, D; Arow, M; Freimark, D; Hochhauser, E; Kornowski, R; Nudelman, V; Shainberg, A; Waldman, M; Yadin, D1
Boulton, ME; Grant, MB; Li Calzi, S; Obukhov, AG; Oudit, GY; Prasad, R; Raizada, MK; Stevens, BR1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J1
Chopra, T; Draghici, S; Elahi, M; Esber, Z; Gabali, A; Hanoudi, S; Samavati, L; Sano, D; Taha, M1
Aburaya, J; Fujimoto, S; Fukuda, A; Kikuchi, M; Kitamura, K; Nagata, S; Nagatomo, M; Sato, Y1
Bers, DM; Bossuyt, J; Hegyi, B; Ko, CY1
Pawlikowski, M; Winczyk, K1
Bahreini, E; Nabi-Afjadi, M; Rezaei-Chianeh, Y1
Bader, M; Rein, J1
Scholey, JW; Williams, VR1
Guo, X; Liu, L; Liu, M; Peng, Y; Wu, XF; Yuan, JL; Yue, ZH; Zheng, XN1
Chen, L; Hao, S; Li, N; Lin, D; Ren, M; Yan, L; Yang, C; Zhu, P1
Arkun, Y; Cizmeci, D1
Abbott, GW; Anand, M; Christini, DJ; Hu, Z; Kant, R; King, EC; Krogh-Madsen, T1
Costa-Neto, CM; Duarte, DA; Lima, V; Maria, AG; Parreiras-E-Silva, LT; Prando, EC; Rodríguez, DY; Santos, GA; Souza, PP1
Bódi, N; Kovacs, G; Nyengaard, JR; Razga, Z; Talapka, P1
Jing, D; Liu, M; Liu, Y; Wang, Y; Yin, S1
Chodavarapu, H; Lazartigues, E; Pedersen, KB; Porretta, C; Robinson, LK1
James, PD; Tan, HK; Wong, F1
Campbell, DJ1
Adler, G; Baudrand, R; Garza, A; Hopkins, P; Jeunemaitre, X; Pojoga, L; Vaidya, A; Vöhringer, P; Williams, G; Williams, J; Yao, T1
Feng, C; Guo, L; Jin, H; Li, Y; Yang, X1
Bae, UJ; Cha, SA; Gao, S; Kim, SH; Park, BH; Park, BM; Park, WH1
Boas, WW; Dos Santos, RA; Nogueira, AI; Pereira, RM; Ribeiro-Oliveira, A; Simões e Silva, AC1
Arellano-Plancarte, A; Castillo-Hernandez, JR; Olivares-Reyes, JA1
Baker, KM; Kumar, R; Singh, VP1
Bagi, Z; Edes, I; Erdei, N; Feher, A; Henrion, D; Kaley, G; Koller, A; Papp, Z; Rutkai, I1
Hunyady, L1
Baker, KM; Choudhary, R; Guleria, RS; Pan, J; Tanaka, T1
Dikalov, S1
Akhtar, S; Al-Farsi, O; Benter, IF; Chandrasekhar, B; Dhaunsi, GS; Yousif, MH1
Baker, KM; Kumar, R; Thomas, CM; Yong, QC1
Bernardi, S; Burns, WC; Burrell, LM; Fabris, B; Grixti, E; Johnston, C; Pickering, R; Sakoda, M; Thomas, MC; Tikellis, C; Toffoli, B; Tsorotes, D; Velkoska, E1
Chihara, Y; Denda, A; Fujii, K; Kuniyasu, H; Luo, Y; Ohmori, H; Sasahira, T; Shimomoto, T; Tatsumoto, N1
Burns, KD; Fergusson, D; Hiremath, S; Jadhav, D; Kennedy, CR; Knoll, G; Srivaratharajah, K; Xiao, F; Zimpelmann, J1
Mehta, AA; Patel, BM1
Annes, JP; Forman, JP; Sun, B; Underwood, PC; Vaidya, A; Williams, GH; Williams, JS1
Mansoor, GA; Thavarajah, S1
Malik, RA1
Engeli, S; Gorzelniak, K; Janke, J; Luft, FC; Sharma, AM1
Gaede, P; Jensen, GV; Larsen, N; Parving, HH; Pedersen, O; Vedel, P1
Epstein, PN; Metreveli, NS; Ren, J; Ye, G1
Fisher, ND; Price, DA1
Kumar, A; McFarlane, SI; Sowers, JR1
Chen, WY; Huang, XR; Lan, HY; Truong, LD1
Brands, MW; Cloud, LJ1
Asano, T; Ogihara, T1
Ando, K1
Gaede, PH; Jensen, GV; Jepsen, PV; Larsen, JN; Parving, HH; Pedersen, OB1
Sidorenko, BA; Ugriumova, MO1
Marshall, SM1
Frohlich, ED; Sowers, JR1
Ferro, A; Hurairah, H1
Jabs, K; Kon, V1
Kohno, M1
Campbell, RC1
Mehta, JL1
Arikawa, E; Chou, E; Clermont, A; Feener, EP; He, Z; Isshiki, K; King, GL; Ma, RC; Opland, DM; Schoen, FJ; Scott, JA; Way, KJ1
Catt, KJ; Hunyady, L1
Cooper, ME; Thomas, MC; Tikellis, C1
Busse, R; Fleming, I; Kohlstedt, K1
Garaliene, V1
Nickenig, G; Ostergren, J; Struijker-Boudier, H1
Chan, CM; Lau, YK; Wong, KS; Woo, KT1
Cohn, JN1
Carvalheira, JB; Carvalho-Filho, MA; Saad, MJ; Velloso, LA1
Huang, Y; Lau, CW; Leung, FP; Lin, SG; Wong, WT; Yu, XY; Yung, LM; Zhong, JC1
de Cavanagh, EM; Ferder, L; Ferder, M; Inserra, F1
Boyle, AJ; Connelly, KA; Kelly, DJ1
Fulton, D; Marrero, MB; Stepp, D; Stern, DM1
Davis, SN; Perkins, JM1
Cardwell, RJ; Webb, RC1
Drury, PL1
Beretta-Piccoli, C; Keusch, G; Weidmann, P1
Beretta-Piccoli, C; Fraser, R; Weidmann, P1
Azukizawa, S; Hosojima, H; Kigoshi, T; Morimoto, S; Uchida, K; Yamamoto, I1
Mayes, DM; Tuck, ML1
Khristov, V; Maleeva, A; Turkolev, N1
Maezawa, H; Odakura, T; Sugiyama, H; Uchimura, I1
Cole, M; Ferriss, JB; Gonggrijp, H; O'Sullivan, DJ; Sullivan, PA1
Christlieb, AR; Gleason, RE; Rand, LI; Rhie, FH; Sandor, T; Shah, ST; Soeldner, JS1
Beretta-Piccoli, C; Weidmann, P1
Crowley, MJ; Ferriss, JB; Gonggrijp, H; O'Sullivan, DJ; Sullivan, PA1
Abe, K; Arima, S; Ito, S; Omata, K; Takeuchi, K1
Fisher, ND; Hollenberg, NK1
Brown, L; Sernia, C1
Beretta-Piccoli, C; Cusi, D; Elshater-Zanetti, F; Shaw, S; Weidmann, P1
Adams-Huet, B; Fenves, AZ; Mitchell, HC; Mulcahy, W; Smith, RD; Toto, RD1
Choi, Y; Choo, JA; Gwon, HC; Huh, JE; Kim, DK; Kim, JW; Kim, S; Lee, WR; Rhee, CH; Ryu, JC1
Weir, MR1
Carlson, SH; Shelton, J; White, CR; Wyss, JM1
Schrier, RW1
Hollenberg, NK1
Camilión de Hurtado, MC; Cingolani, HE; Pérez, NG1
Cooper, ME; de Gasparo, M; Webb, RL1
Han, HJ; Park, SH; Shin, SS1
Srivastava, AK1
Frisbee, JC; Stepp, DW1
Li, D; Mehta, JL1
Kokot, F1
Iba, K; Morii, H; Okamoto, T; Tsugawa, S; Ueno, T; Wada, M1
Cokkinos, DV; Demopoulos, JN; Gardikas, CD; Haralambakis, AG; Heimonas, ET; Thalassinos, NC; Voridis, EM1
Kim, KS; Kornel, L; Morimoto, S; Takeda, R; Uchida, K; Yamamoto, I1
Beretta-Piccoli, C; Glück, Z; Grimm, M; Keusch, G; Meier, A; Mujagic, M; Weidmann, P; Ziegler, WH1
Ferriss, JB; Gonggrijp, H; Long, AA; O'Sullivan, DJ; Sullivan, PA1
Aiello, LM; Cabral, BV; Christlieb, AR; Gleason, RE; Icasas-Cabral, EA; Janka, HU; Kraus, B; Solano, A1
Christlieb, AR2
Hems, DA2
Ahmad, MR; Ahmed, SS; Haider, B; Levinson, GE; Lyons, MM; Oldewurtel, HA; Regan, TJ1
Ikeda, T1
Donato, L1
Fujishima, M; Fujita, S; Hirakata, H; Iino, K; Ishida, I; Kashiwagi, M; Okuda, S; Yoshinari, M1
Inaba, M; Ishii, J; Itabashi, A; Katayama, S; Kawazu, S; Komeda, K; Maruno, Y; Omoto, A1
Campbell, WG; Gahnem, F; Halimi, JM; Laragh, JH; Rubattu, S; Sealey, JE; von Lutterotti, N1
Azukizawa, S; Hosojima, H; Imaizumi, N; Kigoshi, T; Morimoto, S; Uchida, K; Yamamoto, I1
Hassid, A; Kreisberg, JI1
Ikeda, M; Koshida, H; Miyamori, I; Morise, T; Nagai, K; Takeda, R; Takeda, Y; Yasuhara, S1
Hattori, N; Ikeda, T; Iwase, N; Kiyokawa, H; Noto, Y; Takata, S; Yagi, S; Yamamoto, M1
Morandini, G; Palmas, S; Piras, L1
Liebermeister, H; Schilling, WH1
Yoshida, H1
De Bono, E; Mills, IH; Wilson, RJ1
Mullane, JF1
Braaten, JT; Christlieb, AR; Munichoodappa, C1
Barontini de Moyano, MB; Hauger-Klevene, JH1

Reviews

50 review(s) available for angiotensin ii and Diabetes Mellitus

ArticleYear
Diabetes, heart damage, and angiotensin II. What is the relationship link between them? A minireview.
    Endocrine regulations, 2022, Feb-18, Volume: 56, Issue:1

    Topics: Angiotensin II; Diabetes Mellitus; Diabetic Cardiomyopathies; Heart; Heart Injuries; Humans; Renin-Angiotensin System

2022
Elucidating glial responses to products of diabetes-associated systemic dyshomeostasis.
    Progress in retinal and eye research, 2023, Volume: 94

    Topics: Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Glucose; Humans; Hyperglycemia; Hypertension; Neuroglia; Palmitic Acid

2023
Metabolic Syndrome and Cardiac Remodeling Due to Mitochondrial Oxidative Stress Involving Gliflozins and Sirtuins.
    Current hypertension reports, 2023, Volume: 25, Issue:6

    Topics: Angiotensin II; Cardiovascular Diseases; Diabetes Mellitus; Fibrosis; Humans; Hypertension; Metabolic Syndrome; Oxidative Stress; Sirtuins; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling

2023
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Endocrine and metabolic aspects of COVID-19.
    Endokrynologia Polska, 2021, Volume: 72, Issue:3

    Topics: Aging; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme 2; COVID-19; Diabetes Mellitus; Humans; Melatonin; Obesity; Renin-Angiotensin System

2021
Molecular Mechanisms Involved in Intrarenal Renin-Angiotensin and Alternative Pathways in Diabetic Nephropathy - A Review.
    The review of diabetic studies : RDS, 2021,Spring, Volume: 17, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Renin; Renin-Angiotensin System

2021
Renin-Angiotensin System in Diabetes.
    Protein and peptide letters, 2017, Nov-17, Volume: 24, Issue:9

    Topics: Angiotensin I; Angiotensin II; Animals; Diabetes Mellitus; Humans; Peptide Fragments; Renin-Angiotensin System

2017
Angiotensin-converting enzyme 2 and renal disease.
    Current opinion in nephrology and hypertension, 2018, Volume: 27, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Diabetes Mellitus; Fibrosis; Humans; Inflammation; Kidney; Kidney Diseases; Peptidyl-Dipeptidase A; Renin-Angiotensin System

2018
Non-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.
    Clinical science (London, England : 1979), 2014, Volume: 126, Issue:11

    Topics: Angiotensin II; Angiotensins; Animals; Arrestins; beta-Arrestins; Bone Resorption; Bradykinin; Central Nervous System Diseases; Diabetes Mellitus; Gene Expression Regulation; Humans; Kinins; Ligands; Neoplasms; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Signal Transduction

2014
The renin-angiotensin system and diabetes: an update.
    Vascular health and risk management, 2008, Volume: 4, Issue:4

    Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin-Converting Enzyme 2; Angiotensinogen; Animals; Diabetes Mellitus; Endothelium, Vascular; Humans; Hyaluronan Receptors; Insulin; Peptide Fragments; Peptidyl-Dipeptidase A; Renin; Renin-Angiotensin System; Signal Transduction

2008
Angiotensin II and the development of insulin resistance: implications for diabetes.
    Molecular and cellular endocrinology, 2009, Apr-29, Volume: 302, Issue:2

    Topics: Angiotensin II; Diabetes Mellitus; Humans; Insulin Resistance; Renin-Angiotensin System

2009
The intracellular renin-angiotensin system in the heart.
    Current hypertension reports, 2009, Volume: 11, Issue:2

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Clinical Trials as Topic; Diabetes Mellitus; Fibroblasts; Humans; Hypertension; Kidney; Muscle, Smooth, Vascular; Myocytes, Cardiac; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ventricular Remodeling

2009
Cross talk between mitochondria and NADPH oxidases.
    Free radical biology & medicine, 2011, Oct-01, Volume: 51, Issue:7

    Topics: Aging; Angiotensin II; Animals; Antioxidants; Atherosclerosis; Diabetes Mellitus; Humans; Hypertension; Mice; Mitochondria; NADPH Oxidases; Neurodegenerative Diseases; Nitric Oxide Synthase Type III; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Stress; Piperidines; Rabbits; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Xanthine Oxidase

2011
Intracardiac intracellular angiotensin system in diabetes.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2012, Mar-01, Volume: 302, Issue:5

    Topics: Angiotensin II; Animals; Cricetinae; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Heart; Hyperglycemia; Mice; Myocardium; Rats; Renin-Angiotensin System

2012
Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases.
    European journal of pharmacology, 2012, Dec-15, Volume: 697, Issue:1-3

    Topics: Aldosterone; Angiotensin II; Animals; Autocrine Communication; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Humans; Paracrine Communication; Renin-Angiotensin System; Signal Transduction; Water-Electrolyte Balance

2012
Are clinical endpoint benefits of angiotensin converting enzyme inhibitors independent of their blood pressure effects?
    Current hypertension reports, 2002, Volume: 4, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Cardiovascular System; Diabetes Mellitus; Diabetic Nephropathies; Endothelium, Vascular; Humans; Hypertension; Kidney Diseases; Receptors, Angiotensin; Renin-Angiotensin System

2002
The renin-angiotensin system in blacks: active, passive, or what?
    Current hypertension reports, 2003, Volume: 5, Issue:3

    Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Black People; Diabetes Mellitus; Humans; Kidney; Regional Blood Flow; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary

2003
Mechanisms by which angiotensin-converting enzyme inhibitors prevent diabetes and cardiovascular disease.
    The American journal of cardiology, 2003, Jun-19, Volume: 91, Issue:12A

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Diabetes Complications; Diabetes Mellitus; Humans; Insulin Resistance; Kidney Failure, Chronic; Rats

2003
[Hemodynamic factors].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:7

    Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; Hypertension; Insulin; Insulin Resistance; Oxidative Stress; Rats; Rats, Inbred Dahl; Rats, Sprague-Dawley; Signal Transduction

2003
[Oxidative stress].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61, Issue:7

    Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Insulin Resistance; Lipid Metabolism; Nitric Oxide; Oxidants; Oxidative Stress; Reactive Oxygen Species

2003
[New perspectives of the use of angiotensin II receptor blocker].
    Kardiologiia, 2003, Volume: 43, Issue:6

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Hyperuricemia; Losartan; Receptors, Angiotensin

2003
Insulin and insulin resistance: impact on blood pressure and cardiovascular disease.
    The Medical clinics of North America, 2004, Volume: 88, Issue:1

    Topics: Angiotensin II; Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Humans; Hypertension; Insulin; Insulin Resistance; Obesity; Risk Factors

2004
The role of the endothelium in the control of vascular function.
    International journal of clinical practice, 2004, Volume: 58, Issue:2

    Topics: Angiotensin II; Arteriosclerosis; Cardiovascular Diseases; Cell Adhesion Molecules; Coagulants; Diabetes Mellitus; Endothelin-1; Endothelium, Vascular; Female; Humans; Pre-Eclampsia; Pregnancy; Vasoconstrictor Agents; Vasodilator Agents

2004
Angiotensin in atherosclerosis.
    Current opinion in nephrology and hypertension, 2004, Volume: 13, Issue:3

    Topics: Angiotensin II; Arteriosclerosis; Diabetes Mellitus; Disease Progression; Estrogens; Humans; Hyperlipidemias; Hypertension; Inflammation; Insulin Resistance; Risk Factors

2004
[Hypertension in patients with cardiac hypertrophy].
    Nihon rinsho. Japanese journal of clinical medicine, 2004, Volume: 62 Suppl 3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors

2004
The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    The Canadian journal of cardiology, 2004, Volume: 20 Suppl B

    Topics: Angiotensin II; Atherosclerosis; Biomarkers; Coronary Artery Disease; Diabetes Mellitus; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; Lipoproteins, LDL; Myocardial Ischemia; Oxidative Stress; Predictive Value of Tests; Receptors, Oxidized LDL; Risk Factors; Scavenger Receptors, Class E; Sensitivity and Specificity; Severity of Illness Index; Signal Transduction

2004
Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II.
    Molecular endocrinology (Baltimore, Md.), 2006, Volume: 20, Issue:5

    Topics: Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; Neoplasms; Receptor, Angiotensin, Type 1; Signal Transduction

2006
Role of the renin-angiotensin system in the endocrine pancreas: implications for the development of diabetes.
    The international journal of biochemistry & cell biology, 2006, Volume: 38, Issue:5-6

    Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Animals; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fibrosis; Humans; Hyperglycemia; Hypoglycemia; Islets of Langerhans; Pancreas; Peptidyl-Dipeptidase A; PPAR gamma; Receptors, Angiotensin; Renin; Renin-Angiotensin System

2006
The tissue renin-angiotensin system and intracellular signalling.
    Current opinion in nephrology and hypertension, 2006, Volume: 15, Issue:1

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Diabetes Mellitus; Humans; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Signal Transduction

2006
[The main determinants of endothelial dysfunction].
    Medicina (Kaunas, Lithuania), 2006, Volume: 42, Issue:5

    Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Arteriosclerosis; Biological Availability; Diabetes Mellitus; Endothelium, Vascular; Free Radicals; Heart Failure; Homocysteine; Humans; Hypertension; Hypolipidemic Agents; Middle Aged; Models, Biological; Muscle, Smooth, Vascular; Nitric Oxide; Oxidative Stress; Potassium Channels; Reactive Oxygen Species; Renal Insufficiency; Risk Factors; Vasodilation

2006
Clinical evidence for the cardiovascular benefits of angiotensin receptor blockers.
    Journal of the renin-angiotensin-aldosterone system : JRAAS, 2006, Volume: 7 Suppl 1

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Humans; Hypertension; Kidney Diseases; Renin-Angiotensin System

2006
[Insulin and angiotensin II signaling pathways cross-talk: implications with the association between diabetes mellitus, arterial hypertension and cardiovascular disease].
    Arquivos brasileiros de endocrinologia e metabologia, 2007, Volume: 51, Issue:2

    Topics: Angiotensin II; Animals; Diabetes Mellitus; Humans; Hypertension; Insulin; Insulin Resistance; MAP Kinase Signaling System; Signal Transduction; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins

2007
From mitochondria to disease: role of the renin-angiotensin system.
    American journal of nephrology, 2007, Volume: 27, Issue:6

    Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Diabetes Mellitus; Humans; Hypertension; Mitochondria; Mitochondrial Diseases; Oxidative Stress; Reactive Oxygen Species; Renin-Angiotensin System

2007
Angiotensin II and the cardiac complications of diabetes mellitus.
    Current pharmaceutical design, 2007, Volume: 13, Issue:26

    Topics: Angiotensin II; Animals; Diabetes Complications; Diabetes Mellitus; Heart Diseases; Humans; Up-Regulation

2007
Angiotensin II-induced signaling pathways in diabetes.
    Current diabetes reviews, 2005, Volume: 1, Issue:2

    Topics: Angiotensin II; Cell Division; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Glomerular Mesangium; Glycation End Products, Advanced; Humans; Hyperglycemia; Muscle, Smooth, Vascular; Reactive Oxygen Species; Signal Transduction

2005
The renin-angiotensin-aldosterone system: a pivotal role in insulin sensitivity and glycemic control.
    Current opinion in endocrinology, diabetes, and obesity, 2008, Volume: 15, Issue:2

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus; Homeostasis; Humans; Hypertension; Insulin; Insulin Resistance; Receptor, Angiotensin, Type 1; Renin-Angiotensin System

2008
Diabetes and arterial hypertension.
    Diabetologia, 1983, Volume: 24, Issue:1

    Topics: Adrenergic beta-Antagonists; Adult; Aged; Aging; Angiotensin II; Antihypertensive Agents; Blood Pressure; Catecholamines; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Diuretics; Female; Humans; Hypertension; Insulin; Male; Middle Aged; Obesity; Renin; Sodium; Systole; Vascular Diseases

1983
Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word?
    Hypertension (Dallas, Tex. : 1979), 1995, Volume: 26, Issue:4

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus; Humans; Kidney; Renal Circulation; Renin; Renin-Angiotensin System

1995
Angiotensin receptors in cardiovascular diseases.
    Clinical and experimental pharmacology & physiology, 1994, Volume: 21, Issue:10

    Topics: Acromegaly; Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Mellitus; Humans; Receptors, Angiotensin; Renin-Angiotensin System; Thyroid Diseases

1994
Diabetes and hypertension: blood pressure control and consequences.
    American journal of hypertension, 1999, Volume: 12, Issue:12 Pt 1-2

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Humans; Hypertension; Kidney Failure, Chronic; Myocardial Contraction

1999
Treating high-risk diabetic hypertensive patients with comorbid conditions.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Disease Progression; Humans; Hypertension; Kidney Failure, Chronic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors

2000
Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2000, Volume: 36, Issue:3 Suppl 1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Blood Volume; Clinical Trials as Topic; Diabetes Mellitus; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Kidney; Peptidyl-Dipeptidase A; Proteinuria; Renin-Angiotensin System; Vasodilator Agents; Water-Electrolyte Balance

2000
Angiotensin receptor blockers and the kidney: possible advantages over ACE inhibition?
    Cardiovascular drug reviews, 2001,Spring, Volume: 19, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; Hypertension; Kidney; Kidney Diseases; Kidney Failure, Chronic; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2

2001
High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review).
    International journal of molecular medicine, 2002, Volume: 9, Issue:1

    Topics: Angiotensin II; Animals; Diabetes Mellitus; Diabetic Angiopathies; Enzyme Activation; Hyperglycemia; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; NF-kappa B; Protein Kinase C

2002
Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor.
    Journal of the American College of Cardiology, 2002, May-01, Volume: 39, Issue:9

    Topics: Angiotensin II; Coronary Artery Disease; Diabetes Mellitus; Endothelium, Vascular; Gene Expression; Humans; Myocardial Ischemia; Receptors, LDL; Receptors, Oxidized LDL; Scavenger Receptors, Class E; Tumor Necrosis Factor-alpha; Up-Regulation

2002
[The renin-angiotensin-aldosterone system in diabetics].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1978, Jul-31, Volume: 33, Issue:31

    Topics: Aldosterone; Angiotensin II; Animals; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Humans; Hypertension; Kidney; Renin

1978
The greater renin system. Its prorenin-directed vasodilator limb. Relevance to diabetes mellitus, pregnancy, and hypertension.
    American journal of hypertension, 1991, Volume: 4, Issue:12 Pt 1

    Topics: Angiotensin II; Diabetes Mellitus; Enzyme Precursors; Female; Humans; Hypertension; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy in Diabetics; Renin; Renin-Angiotensin System; Vasoconstriction; Vasodilation

1991
Functional properties of glomerular cells in culture.
    Mineral and electrolyte metabolism, 1986, Volume: 12, Issue:1

    Topics: Angiotensin II; Animals; Arginine Vasopressin; Calcium; Cell Adhesion; Cells, Cultured; Contractile Proteins; Cyclic AMP; Diabetes Mellitus; Dinoprostone; Epithelial Cells; Glomerular Mesangium; Glomerulonephritis; Humans; Kidney Glomerulus; Platelet Activating Factor; Prostaglandins; Prostaglandins E; Rats

1986
[Endocrinology].
    Naika. Internal medicine, 1969, Volume: 23, Issue:1

    Topics: 17-Ketosteroids; Adrenal Glands; Adrenal Medulla; Androgens; Angiotensin II; Diabetes Mellitus; Diabetic Nephropathies; Endocrine Glands; Estrogens; Growth Hormone; Humans; Insulin; Insulin Secretion; Lipid Metabolism; Prostaglandins; Renin; Thyroxine-Binding Proteins

1969
Diabetes and hypertensive vascular disease. Mechanisms and treatment.
    The American journal of cardiology, 1973, Sep-20, Volume: 32, Issue:4

    Topics: Alloxan; Angiotensin II; Animals; Blood Volume; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Hypertension; Hypertension, Renal; Juxtaglomerular Apparatus; Nephrosclerosis; Rats; Renin; Sympathetic Nervous System

1973

Trials

6 trial(s) available for angiotensin ii and Diabetes Mellitus

ArticleYear
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
    Annales medico-psychologiques, 2021, Volume: 179, Issue:2

    Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses

2021
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
    The New England journal of medicine, 2003, Jan-30, Volume: 348, Issue:5

    Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins

2003
[The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
    Ugeskrift for laeger, 2003, Jun-23, Volume: 165, Issue:26

    Topics: Amputation, Surgical; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Combined Modality Therapy; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Exercise; Female; Humans; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Male; Middle Aged; Myocardial Infarction; Obesity; Risk Factors; Smoking Cessation; Stroke; Vitamins

2003
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1996, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renal Plasma Flow

1996
Vascular reactivity to angiotensin II and to norepinephrine in diabetic subjects.
    Diabetes, 1976, Volume: 25, Issue:4

    Topics: Angiotensin II; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus; Diabetic Retinopathy; Dose-Response Relationship, Drug; Humans; Norepinephrine; Renin

1976
Effects of a new calcium antagonist, manidipine, on the renal hemodynamics and the vasoactive humoral factors in patients with diabetes mellitus.
    Blood pressure. Supplement, 1992, Volume: 3

    Topics: Adult; Angiotensin II; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Complications; Diabetes Mellitus; Dihydropyridines; Endothelins; Female; Humans; Hypertension; Male; Middle Aged; Nitrobenzenes; Piperazines; Renal Circulation

1992

Other Studies

77 other study(ies) available for angiotensin ii and Diabetes Mellitus

ArticleYear
    Clinical and experimental hypertension (New York, N.Y. : 1993), 2022, Aug-18, Volume: 44, Issue:6

    Topics: Adult; Angiotensin II; Animals; Athletic Performance; Blood Pressure; COVID-19; Diabetes Mellitus; Humans; Hypertension; Isoproterenol; Male; Muscle Fatigue; Nitric Oxide; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Receptors, Adrenergic; Running; Soccer; Streptozocin; Wine; Young Adult

2022
Broad-acting therapeutic effects of miR-29b-chitosan on hypertension and diabetic complications.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2022, 11-02, Volume: 30, Issue:11

    Topics: Angiotensin II; Animals; Chitosan; Diabetes Complications; Diabetes Mellitus; Disease Models, Animal; Fibrosis; Humans; Hypertension; Mice; Mice, Inbred Strains; Mice, Knockout, ApoE; MicroRNAs; Thiolester Hydrolases

2022
Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
    Cardiovascular diabetology, 2020, 01-10, Volume: 19, Issue:1

    Topics: Angiotensin II; Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Diabetes Mellitus; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Glucosides; Inflammation Mediators; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Rats, Sprague-Dawley; Sodium-Calcium Exchanger; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchanger 1; Ventricular Function, Left

2020
SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
    Diabetes, 2020, Volume: 69, Issue:9

    Topics: Angiotensin II; Angiotensin-Converting Enzyme 2; Betacoronavirus; Bone Marrow; Coronavirus Infections; COVID-19; Diabetes Mellitus; Humans; Intestinal Mucosa; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; SARS-CoV-2; Severity of Illness Index

2020
Platelets and renal failure in the SARS-CoV-2 syndrome.
    Platelets, 2021, Jan-02, Volume: 32, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Aged, 80 and over; Angiotensin II; Angiotensin-Converting Enzyme 2; Blood Platelets; Comorbidity; COVID-19; Diabetes Mellitus; Female; Fibrin Fibrinogen Degradation Products; Glomerular Filtration Rate; Humans; Hypertension; Male; Mean Platelet Volume; Middle Aged; Pandemics; Receptors, Virus; Renin-Angiotensin System; SARS-CoV-2; Thrombocytopenia; Thrombophilia; Young Adult

2021
Development of a novel AlphaLISA ImmunoAssay for Big angiotensin-25.
    Nephrology (Carlton, Vic.), 2021, Volume: 26, Issue:5

    Topics: Adult; Angiotensin II; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged

2021
Two-hit mechanism of cardiac arrhythmias in diabetic hyperglycaemia: reduced repolarization reserve, neurohormonal stimulation, and heart failure exacerbate susceptibility.
    Cardiovascular research, 2021, 12-17, Volume: 117, Issue:14

    Topics: Action Potentials; Angiotensin II; Animals; Arrhythmias, Cardiac; Blood Glucose; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Diabetes Mellitus; Disease Models, Animal; Heart Conduction System; Heart Failure; Heart Rate; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Potassium Channels; Rabbits; Ryanodine Receptor Calcium Release Channel

2021
[Effect of Point-moxibustion and Electroacupuncture on the Expression of Endothelial Nitric Oxide Synthase mRNA and Angiotensin 2 mRNA in Gastric Antrum in Diabetic Gastroparesis Rats].
    Zhen ci yan jiu = Acupuncture research, 2017, Jun-25, Volume: 42, Issue:3

    Topics: Acupuncture Points; Angiotensin II; Animals; Diabetes Mellitus; Electroacupuncture; Gastrointestinal Motility; Gastroparesis; Moxibustion; Nitric Oxide Synthase Type III; Pyloric Antrum; Rats; Rats, Sprague-Dawley; RNA, Messenger

2017
Angiotensin II regulates collagen metabolism through modulating tissue inhibitor of metalloproteinase-1 in diabetic skin tissues.
    Diabetes & vascular disease research, 2013, Volume: 10, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cells, Cultured; Collagen; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Fibroblasts; Male; Matrix Metalloproteinase 1; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Skin; Tissue Inhibitor of Metalloproteinase-1

2013
Regulatory networks and complex interactions between the insulin and angiotensin II signalling systems: models and implications for hypertension and diabetes.
    PloS one, 2013, Volume: 8, Issue:12

    Topics: Angiotensin II; Diabetes Mellitus; Feedback, Physiological; Humans; Hypertension; Insulin; Models, Biological; Receptor Cross-Talk; Renin-Angiotensin System; Signal Transduction; Vasodilation

2013
Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death.
    Circulation. Cardiovascular genetics, 2014, Volume: 7, Issue:1

    Topics: Anemia; Angiotensin II; Angiotensinogen; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Diabetes Mellitus; Dyslipidemias; Gene Regulatory Networks; Genotype; Heterozygote; Hyperkalemia; Ischemia; Long QT Syndrome; Mice; Mice, Knockout; Potassium Channels, Voltage-Gated

2014
Heterogeneous downregulation of angiotensin II AT1-A and AT1-B receptors in arterioles in STZ-induced diabetic rat kidneys.
    BioMed research international, 2014, Volume: 2014

    Topics: Angiotensin II; Animals; Arterioles; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Models, Animal; Kidney; Myocytes, Smooth Muscle; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin

2014
Overexpression of angiotensin II type 2 receptor promotes apoptosis and impairs insulin secretion in rat insulinoma cells.
    Molecular and cellular biochemistry, 2015, Volume: 400, Issue:1-2

    Topics: Angiotensin II; Animals; Apoptosis; Diabetes Mellitus; Gene Expression Regulation; Humans; Insulin; Insulin Secretion; Insulinoma; Rats; Receptor, Angiotensin, Type 2; Signal Transduction

2015
Dynamics of ADAM17-Mediated Shedding of ACE2 Applied to Pancreatic Islets of Male db/db Mice.
    Endocrinology, 2015, Volume: 156, Issue:12

    Topics: ADAM Proteins; ADAM17 Protein; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Experimental; Disease Progression; Insulin-Secreting Cells; Insulinoma; Islets of Langerhans; Male; Mice; Pancreatic Neoplasms; Peptidyl-Dipeptidase A; Rats; RNA, Messenger

2015
Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Digestive diseases and sciences, 2016, Volume: 61, Issue:10

    Topics: Administration, Intravenous; Aged; Albumins; Aldosterone; Angiotensin II; Ascites; Cardiovascular Diseases; Diabetes Mellitus; Female; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Norepinephrine; Odds Ratio; Paracentesis; Pilot Projects; Portasystemic Shunt, Transjugular Intrahepatic; Renin; Risk Factors

2016
Letter by Campbell Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation, 2016, Apr-19, Volume: 133, Issue:16

    Topics: Adrenal Glands; Aldosterone; Angiotensin II; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Renin

2016
Response to Letter Regarding Article, "Statin Use and Adrenal Aldosterone Production in Hypertensive and Diabetic Subjects".
    Circulation, 2016, Apr-19, Volume: 133, Issue:16

    Topics: Adrenal Glands; Aldosterone; Angiotensin II; Diabetes Mellitus; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Renin

2016
[In vivo study of the renoprotective effects of EGCG in diabetic db/db mice].
    Zhonghua yi xue za zhi, 2016, May-10, Volume: 96, Issue:17

    Topics: Angiotensin II; Animals; Catechin; Diabetes Mellitus; Kidney; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 3; NADPH Oxidases; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Proteinuria; Proto-Oncogene Proteins c-akt

2016
Oxidative stress increases the risk of pancreatic β cell damage in chronic renal hypertensive rats.
    Physiological reports, 2016, Volume: 4, Issue:16

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Captopril; Deoxyguanosine; Diabetes Mellitus; Hypertension; Insulin; Insulin Secretion; Insulin-Secreting Cells; Kidney; Male; Models, Animal; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Pancreas; Rats; Rats, Sprague-Dawley; Thioctic Acid

2016
Activation of prostaglandin E2 EP1 receptor increases arteriolar tone and blood pressure in mice with type 2 diabetes.
    Cardiovascular research, 2009, Jul-01, Volume: 83, Issue:1

    Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Diabetes Mellitus; Dinoprostone; Disease Models, Animal; Hypertension; Male; Mice; Mice, Mutant Strains; Muscle, Skeletal; Prostaglandin Antagonists; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP1 Subtype; Vascular Resistance; Vasoconstrictor Agents; Xanthones

2009
Physiological and pathological actions of the renin-angiotensin system.
    Molecular and cellular endocrinology, 2009, Apr-29, Volume: 302, Issue:2

    Topics: Angiotensin II; Diabetes Mellitus; Humans; Neoplasms; Receptor, Angiotensin, Type 1; Renin-Angiotensin System

2009
Retinoic acid receptor-mediated signaling protects cardiomyocytes from hyperglycemia induced apoptosis: role of the renin-angiotensin system.
    Journal of cellular physiology, 2011, Volume: 226, Issue:5

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Apoptosis; Blood Glucose; Cells, Cultured; Diabetes Mellitus; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hyperglycemia; Hypoglycemic Agents; Male; Myocytes, Cardiac; Oxidative Stress; Rats; Rats, Sprague-Dawley; Rats, Zucker; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Receptors, Retinoic Acid; Renin-Angiotensin System; Retinoic Acid Receptor alpha; Retinoid X Receptor alpha; RNA Interference; RNA, Messenger; Signal Transduction; Time Factors; Tretinoin

2011
Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.
    British journal of pharmacology, 2012, Volume: 165, Issue:5

    Topics: Angiotensin I; Angiotensin II; Animals; Body Weight; Diabetes Mellitus; ErbB Receptors; Glucose; Hyperglycemia; Male; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; p38 Mitogen-Activated Protein Kinases; Peptide Fragments; Phosphorylation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Quinazolines; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; src-Family Kinases; Transcriptional Activation; Tyrphostins

2012
Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).
    Clinical science (London, England : 1979), 2012, Volume: 123, Issue:1

    Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Atrial Natriuretic Factor; Diabetes Mellitus; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Random Allocation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Renin-Angiotensin System

2012
Diabetes-associated angiotensin activation enhances liver metastasis of colon cancer.
    Clinical & experimental metastasis, 2012, Volume: 29, Issue:8

    Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chymases; Colonic Neoplasms; Diabetes Complications; Diabetes Mellitus; Glucose; Glycated Hemoglobin; HT29 Cells; Humans; Hyperglycemia; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Oligoribonucleotides, Antisense; Receptor, Angiotensin, Type 1; Renin; RNA Interference; RNA, Small Interfering

2012
Increased urinary angiotensin-converting enzyme 2 in renal transplant patients with diabetes.
    PloS one, 2012, Volume: 7, Issue:5

    Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme 2; Diabetes Mellitus; Female; Humans; Kidney; Kidney Transplantation; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin-Angiotensin System; RNA, Messenger; Sex Factors

2012
The influence of sodium- and calcium-regulatory hormone interventions on adipocytokines in obesity and diabetes.
    Metabolism: clinical and experimental, 2013, Volume: 62, Issue:4

    Topics: Adipokines; Adult; Aged; Angiotensin II; Arterial Pressure; Biomarkers; Calcium; Cholecalciferol; Diabetes Mellitus; Female; Glycated Hemoglobin; Hormones; Humans; Inflammation; Infusions, Intravenous; Male; Middle Aged; Obesity; Renin-Angiotensin System; Resistin; Sodium; Young Adult

2013
No morbidity-mortality. Commentary.
    Diabetic medicine : a journal of the British Diabetic Association, 2002, Volume: 19 Suppl 5

    Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Atenolol; Diabetes Complications; Diabetes Mellitus; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Middle Aged; Morbidity; Patient Selection

2002
Angiotensin blockade prevents type 2 diabetes by formation of fat cells.
    Hypertension (Dallas, Tex. : 1979), 2002, Volume: 40, Issue:5

    Topics: Adipocytes; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Cell Differentiation; Clinical Trials as Topic; Diabetes Mellitus; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypoglycemic Agents; Insulin Resistance; Obesity; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Telmisartan

2002
Metallothionein prevents diabetes-induced deficits in cardiomyocytes by inhibiting reactive oxygen species production.
    Diabetes, 2003, Volume: 52, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Diabetes Complications; Diabetes Mellitus; Enzyme Inhibitors; Gene Expression; Glucose; Losartan; Metallothionein; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; NADPH Oxidases; Onium Compounds; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Spectrometry, Fluorescence

2003
Chymase is upregulated in diabetic nephropathy: implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease.
    Journal of the American Society of Nephrology : JASN, 2003, Volume: 14, Issue:7

    Topics: Adult; Aged; Angiotensin II; Cells, Cultured; Chymases; Collagen; Diabetes Mellitus; Diabetic Nephropathies; Extracellular Matrix; Glomerular Mesangium; Humans; Hypertension; Immunohistochemistry; Kidney; Kidney Tubules; Leukocytes, Mononuclear; Middle Aged; Myocytes, Smooth Muscle; Peptidyl-Dipeptidase A; Serine Endopeptidases; Up-Regulation

2003
Control of arterial pressure by angiotensin II and nitric oxide at the onset of diabetes.
    American journal of hypertension, 2003, Volume: 16, Issue:7

    Topics: Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Enalapril; Hypertension; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents

2003
Inhibition of the renin-angiotensin system: added value in reducing cardiovascular and renal risk?
    Diabetic medicine : a journal of the British Diabetic Association, 2004, Volume: 21, Issue:1

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Humans; Renal Insufficiency; Renin-Angiotensin System; Risk Factors

2004
The renin-angiotensin system: a 21st century perspective.
    Journal of the American Society of Nephrology : JASN, 2004, Volume: 15, Issue:7

    Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Models, Animal; Humans; NG-Nitroarginine Methyl Ester; Reactive Oxygen Species; Renin; Renin-Angiotensin System

2004
Differential regulation of angiotensin II-induced expression of connective tissue growth factor by protein kinase C isoforms in the myocardium.
    The Journal of biological chemistry, 2005, Apr-22, Volume: 280, Issue:16

    Topics: Angiotensin II; Animals; Cells, Cultured; Connective Tissue Growth Factor; Diabetes Mellitus; Gene Expression Regulation; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Isoenzymes; Mice; Myocardium; Myocytes, Cardiac; Protein Kinase C; Rats

2005
ACE inhibitor use and the long-term risk of renal failure in diabetics.
    Kidney international, 2006, Volume: 70, Issue:7

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Diabetes Mellitus; Diabetic Nephropathies; Disease Progression; Follow-Up Studies; Humans; Kidney Failure, Chronic; Proteinuria; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Tretinoin

2006
What is the role of angiotensin-receptor blockade in cardiovascular protection?
    American heart journal, 2006, Volume: 152, Issue:5

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Diabetes Mellitus; Endothelium, Vascular; Humans; Kidney Diseases; Pilot Projects; Renin-Angiotensin System; Research Design; Vascular Diseases; Ventricular Remodeling

2006
The novel peptide apelin regulates intrarenal artery tone in diabetic mice.
    Regulatory peptides, 2007, Dec-04, Volume: 144, Issue:1-3

    Topics: Acetylcholine; Adipokines; Angiotensin II; Animals; Apelin; Apelin Receptors; Blotting, Western; Carrier Proteins; Diabetes Mellitus; Insulin Resistance; Intercellular Signaling Peptides and Proteins; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nitric Oxide Synthase Type III; Receptors, G-Protein-Coupled; Renal Artery; Vasodilation

2007
Diabetes and reactivity of isolated human saphenous vein.
    Clinical physiology (Oxford, England), 1984, Volume: 4, Issue:6

    Topics: Aged; Angiotensin II; Blood Vessels; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Norepinephrine; Phentolamine; Potassium Chloride; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Saphenous Vein; Serotonin; Vasoconstrictor Agents

1984
Responsiveness of plasma renin and aldosterone in diabetes mellitus.
    Kidney international, 1981, Volume: 20, Issue:2

    Topics: Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Furosemide; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Posture; Renin; Renin-Angiotensin System

1981
Responsiveness of plasma 18-hydroxycorticosterone and aldosterone to angiotensin II or corticotropin in nonazotemic diabetes mellitus.
    Diabetes, 1983, Volume: 32, Issue:1

    Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aged; Aldosterone; Angiotensin II; Corticosterone; Diabetes Mellitus; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Uremia

1983
Responsiveness of plasma aldosterone to angiotensin II in patients with diabetes mellitus.
    Endocrinologia japonica, 1983, Volume: 30, Issue:5

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Furosemide; Humans; Hydrocortisone; Male; Middle Aged; Potassium; Renin; Sodium

1983
Mineralocorticoid biosynthesis in patients with hyporeninemic hypoaldosteronism.
    The Journal of clinical endocrinology and metabolism, 1980, Volume: 50, Issue:2

    Topics: Adrenal Insufficiency; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Complications; Diabetes Mellitus; Electrolytes; Humans; Hydrocortisone; Male; Middle Aged; Mineralocorticoids; Posture; Renin

1980
[Renin-angiotensin-aldosterone system in diabetes, arterial hypertension and orthostatic hypotension].
    Vutreshni bolesti, 1980, Volume: 19, Issue:4

    Topics: Adult; Aged; Aldosterone; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Humans; Hypertension; Hypotension, Orthostatic; Male; Middle Aged; Pulse; Renin; Urine

1980
Plasma renin and aldosterone in adult-onset diabetics with persistent proteinuria.
    Japanese journal of medicine, 1981, Volume: 20, Issue:3

    Topics: Aldosterone; Angiotensin II; Bed Rest; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Female; Furosemide; Humans; Male; Middle Aged; Proteinuria; Renin; Renin-Angiotensin System

1981
Plasma angiotensin II and aldosterone in unselected diabetic patients.
    Clinical endocrinology, 1982, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aldosterone; Angiotensin II; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Potassium; Sex Factors; Sodium

1982
Retinal vascular reactivity to norepinephrine and angiotensin II in normals and diabetics.
    Diabetes, 1982, Volume: 31, Issue:12

    Topics: Adult; Angiotensin II; Diabetes Mellitus; Diabetic Retinopathy; Female; Humans; Male; Norepinephrine; Retinal Artery; Vasoconstriction

1982
Exaggerated pressor responsiveness to norepinephrine in nonazotemic diabetes mellitus.
    The American journal of medicine, 1981, Volume: 71, Issue:5

    Topics: Adult; Angiotensin II; Blood Pressure; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Pressoreceptors

1981
Plasma angiotensin II and the control of diabetes mellitus.
    Clinical endocrinology, 1980, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Aged; Angiotensin II; Blood Glucose; Diabetes Mellitus; Female; Hematocrit; Humans; Male; Middle Aged; Potassium; Sodium

1980
High glucose augments angiotensin II action by inhibiting NO synthesis in in vitro microperfused rabbit afferent arterioles.
    Kidney international, 1995, Volume: 48, Issue:3

    Topics: Acetylcholine; Angiotensin II; Animals; Arginine; Arterioles; Diabetes Mellitus; Glucose; Kidney Glomerulus; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroprusside; Perfusion; Rabbits; Vasodilation

1995
Acute sodium loading in patients with uncomplicated diabetes mellitus: renal and hormonal effects.
    Clinical science (London, England : 1979), 1994, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Kidney; Male; Middle Aged; Norepinephrine; Peptides; Renin; Renin-Angiotensin System; Sodium

1994
Polymorphism of angiotensin converting enzyme gene is associated with circulating levels of plasminogen activator inhibitor-1.
    Arteriosclerosis, thrombosis, and vascular biology, 1997, Volume: 17, Issue:11

    Topics: Alleles; Angiotensin II; Asian People; Comorbidity; Coronary Disease; Diabetes Mellitus; Ethnicity; Female; Genetic Variation; Genotype; Humans; Hypercholesterolemia; Hypertension; Korea; Male; Mass Screening; Middle Aged; Obesity; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Polymorphism, Genetic; Postmenopause; Risk Factors; Sequence Deletion; Sex Characteristics; Smoking

1997
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:1 Pt 2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Glucose; Blood Pressure; Carotid Arteries; Circadian Rhythm; Diabetes Mellitus; Diabetes Mellitus, Type 2; Ganglionic Blockers; Heart Rate; Hexamethonium; Hypertension; Losartan; Male; Obesity; Rats; Rats, Zucker; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium Chloride, Dietary; Sympathetic Nervous System; Vasoconstriction

2000
[What is Na+/H+ exchanger guilty of in cardiology?].
    Medicina, 2000, Volume: 60, Issue:5 Pt 2

    Topics: Acidosis; Angiotensin II; Animals; Bicarbonates; Calcium; Carbon Dioxide; Cell Membrane Permeability; Diabetes Mellitus; Endothelins; HEPES; Humans; Hydrogen-Ion Concentration; Hypertension; Hypertrophy, Left Ventricular; Myocardial Contraction; Myocardial Reperfusion; Myocardium; Protons; Sodium Channels; Sodium-Hydrogen Exchangers

2000
High glucose levels alter angiotensin II-induced Ca(2+) uptake via PKC and cAMP pathways in renal proximal tubular cells.
    Kidney & blood pressure research, 2001, Volume: 24, Issue:2

    Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Culture Media, Serum-Free; Cyclic AMP; Diabetes Mellitus; Dose-Response Relationship, Drug; Down-Regulation; Glucose; Ion Transport; Kidney Tubules, Proximal; Protein Kinase C; Rabbits; Receptors, Angiotensin; Second Messenger Systems

2001
Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats.
    American journal of physiology. Heart and circulatory physiology, 2002, Volume: 282, Issue:3

    Topics: Angiotensin II; Animals; Arteries; Arterioles; Blood Pressure; Diabetes Mellitus; Endothelins; Heart Rate; Hypertension; Male; Microcirculation; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Obesity; Phentolamine; Propranolol; Rats; Rats, Zucker; Thinness; Vasoconstriction

2002
The response of plasma renin activity by oral calcium loading in normal subjects and hypertensive and diabetic patients.
    Osaka city medical journal, 1979, Volume: 25, Issue:1

    Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Calcium; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Male; Renin

1979
Effect of digitalis on diminished baroreceptor sensitivity in diabetics.
    Angiology, 1979, Volume: 30, Issue:8

    Topics: Adolescent; Adult; Aged; Angiotensin II; Blood Pressure; Deslanoside; Diabetes Mellitus; Digitalis Glycosides; Female; Heart Rate; Humans; Male; Middle Aged; Pressoreceptors

1979
Selective hypoaldosteronism with hyperreninemia in a diabetic patient.
    The Journal of clinical endocrinology and metabolism, 1979, Volume: 49, Issue:5

    Topics: Aldosterone; Angiotensin II; Blood Pressure; Corticosterone; Desoxycorticosterone; Diabetes Mellitus; Female; Humans; Hydrocortisone; Middle Aged; Potassium; Renin; Sodium

1979
Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus.
    The American journal of medicine, 1979, Volume: 67, Issue:5

    Topics: Adult; Aged; Angiotensin II; Blood Pressure; Blood Volume; Chlorthalidone; Diabetes Complications; Diabetes Mellitus; Diuretics; Female; Humans; Hypertension; Male; Middle Aged; Norepinephrine; Placebos; Sodium

1979
Hypertension, hyperkalaemia and abnormalities of the renin-angiotensin system in diabetes mellitus.
    Irish journal of medical science, 1979, Volume: 148 Suppl 2

    Topics: Angiotensin I; Angiotensin II; Angiotensins; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; Hyperkalemia; Hypertension; Middle Aged; Potassium; Renin

1979
Renin-angiotensin-aldosterone system in diabetes mellitus.
    Diabetes, 1976, Volume: 25, Issue:2 SUPPL

    Topics: Aldosterone; Angiotensin II; Animals; Blood Volume; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetic Ketoacidosis; Diabetic Nephropathies; Diabetic Neuropathies; Humans; Hypertension; Hypotension, Orthostatic; Juxtaglomerular Apparatus; Models, Biological; Potassium; Rats; Renin; Sodium; Vascular Resistance; Water-Electrolyte Balance

1976
Short-term hormonal control of hepatic carbohydrate and lipid catabolism.
    FEBS letters, 1977, Aug-15, Volume: 80, Issue:2

    Topics: Angiotensin II; Animals; Diabetes Mellitus; Epinephrine; Fatty Acids, Nonesterified; Glucagon; Glucose; Glycerides; Hormones; Insulin; Liver; Liver Glycogen; Nucleotides, Cyclic; Obesity; Oxytocin; Parathyroid Hormone; Protein Kinases; Starvation; Stress, Physiological; Vasopressins

1977
Evidence for cardiomyopathy in familial diabetes mellitus.
    The Journal of clinical investigation, 1977, Volume: 60, Issue:4

    Topics: Adult; Aged; Angiocardiography; Angiotensin II; Collagen; Coronary Vessels; Diabetes Complications; Diabetes Mellitus; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Phospholipids; Triglycerides

1977
Short-term hormonal control of fat metabolism in the liver [proceedings].
    Biochemical Society transactions, 1977, Volume: 5, Issue:4

    Topics: Acyl Coenzyme A; Angiotensin II; Animals; Diabetes Mellitus; Epinephrine; Fatty Acids; Hormones; Lipid Metabolism; Liver; Mice; Obesity

1977
[The renin-angiotensin system in diabetes mellitus (author's transl)].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1977, Jul-10, Volume: 66, Issue:7

    Topics: Adolescent; Adult; Aged; Angiotensin II; Diabetes Mellitus; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Renin

1977
[Significance of radioimmunological determination as a tool for clinical research].
    Annali dell'Istituto superiore di sanita, 1975, Volume: 11, Issue:1-2

    Topics: Angiotensin II; Diabetes Mellitus; Growth Hormone; Humans; Hypertension; Insulin; Radioimmunoassay; Research

1975
Hyperreninemia due to increased renal renin synthesis in BioBreeding Worcester rats.
    Hypertension (Dallas, Tex. : 1979), 1990, Volume: 15, Issue:6 Pt 2

    Topics: Angiotensin II; Animals; Diabetes Mellitus; Disease Susceptibility; Hypertension; Immunohistochemistry; Kidney; Rats; Rats, Inbred BB; Rats, Inbred Strains; Renin; RNA, Messenger; Staining and Labeling

1990
Unresponsiveness of plasma mineralocorticoids to angiotensin II in diabetic patients with asymptomatic normoreninemic hypoaldosteronism.
    The Journal of laboratory and clinical medicine, 1985, Volume: 105, Issue:2

    Topics: 18-Hydroxycorticosterone; Adrenocorticotropic Hormone; Adult; Aldosterone; Angiotensin II; Corticosterone; Desoxycorticosterone; Diabetes Mellitus; Female; Humans; Hydrocortisone; Infusions, Parenteral; Injections, Intramuscular; Male; Middle Aged; Renin

1985
Effect of metoclopramide on orthostatic hypotension in diabetes mellitus: failure to demonstrate the role of vasoconstrictive hormones.
    Experimental and clinical endocrinology, 1988, Volume: 91, Issue:2

    Topics: Administration, Oral; Adult; Aldosterone; Angiotensin II; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Humans; Hypotension, Orthostatic; Male; Metoclopramide; Middle Aged; Norepinephrine; Renin; Vasoconstrictor Agents

1988
Effects of insulin on pressor responsiveness and baroreflex function in diabetes mellitus.
    Japanese circulation journal, 1986, Volume: 50, Issue:10

    Topics: Adult; Aged; Angiotensin II; Blood Pressure; Diabetes Mellitus; Female; Humans; Insulin; Male; Middle Aged; Phenylephrine; Pressoreceptors; Vasoconstriction

1986
[Study on peripheral vascular reactivity to angiotensin and noradrenalin in subjects with diabetes mellitus].
    Minerva medica, 1965, Oct-10, Volume: 56, Issue:81

    Topics: Adolescent; Adult; Aged; Angiotensin II; Child; Diabetes Mellitus; Diabetic Angiopathies; Female; Humans; Male; Middle Aged; Norepinephrine; Skin Tests

1965
[Studies of the effect of synthetic angiotensin II on blood sugar levels in persons with manifest and latent diabetes mellitus].
    Klinische Wochenschrift, 1967, Mar-15, Volume: 45, Issue:6

    Topics: Adult; Aged; Angiotensin II; Blood Glucose; Blood Pressure; Diabetes Mellitus; Glucose Tolerance Test; Humans; Injections, Intravenous; Middle Aged

1967
Cardiovascular reflexes and the control of aldosterone production and sodium excretion.
    Proceedings of the Royal Society of Medicine, 1969, Dec-12, Volume: 62, Issue:12

    Topics: Adrenocorticotropic Hormone; Aldosterone; Angiotensin II; Cardiovascular Physiological Phenomena; Diabetes Mellitus; Fludrocortisone; Humans; Hypopituitarism; Hypotension, Orthostatic; Male; Norepinephrine; Posture; Potassium; Reflex; Renin; Sodium

1969
End-vessel reactivity and capillary clearance in diabetes mellitus.
    The Journal of surgical research, 1970, Volume: 10, Issue:2

    Topics: Angiotensin II; Arteriosclerosis; Capillaries; Capillary Permeability; Diabetes Mellitus; Humans; Injections, Intradermal; Skin Tests; Sodium Chloride; Vasomotor System; Wound Healing

1970
Decreased response of plasma renin activity to orthostasis in diabetic patients with orthostatic hypotension.
    Diabetes, 1974, Volume: 23, Issue:10

    Topics: Adult; Aldosterone; Amyloidosis; Angiotensin II; Animals; Blood Pressure; Cattle; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hypertension; Hypotension, Orthostatic; Iodine Radioisotopes; Male; Middle Aged; Norepinephrine; Posture; Pulse; Rabbits; Radioimmunoassay; Renin; Tyramine

1974
The renin-angiotensin system in diabetes mellitus.
    Acta physiologica latino americana, 1974, Volume: 24, Issue:5

    Topics: Angiotensin II; Blood Pressure; Diabetes Mellitus; Epinephrine; Furosemide; Humans; Hypertension; Juxtaglomerular Apparatus; Norepinephrine; Renin; Stimulation, Chemical

1974